Quest Diagnostics is at the forefront of genetics and rare disease diagnostics, offering an integrated approach to support orphan drug development and commercialization. By consolidating our market-leading capabilities, we deliver unmatched expertise and an extensive test menu to pharmaceutical partners.
Our genetic testing services span major clinical areas, including but not limited to:
Quest Diagnostics harnesses a variety of cutting-edge technologies and platforms to provide precise and actionable diagnostic insights.
Understanding the complexity of rare diseases extends beyond traditional genetic testing. Our capabilities further incorporate:
Quest Diagnostics provides a comprehensive suite of services designed to support every phase of orphan drug development, from discovery through post-market surveillance. Leveraging our expertise and capabilities, we offer innovative solutions tailored to the unique needs of orphan drug development.
Quest Diagnostics stands apart with:
Connect with us to explore how Quest Diagnostics can enhance your orphan drug development strategies with our advanced genetics and rare disease solutions.